These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 18580855

  • 21. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
    Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT.
    In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
    [Abstract] [Full Text] [Related]

  • 22. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M, Twisk FN, Ringel K.
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [Abstract] [Full Text] [Related]

  • 23. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
    Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT.
    In Vivo; 2002; 16(3):153-9. PubMed ID: 12182109
    [Abstract] [Full Text] [Related]

  • 24. Psychomotor functioning in chronic fatigue syndrome and major depressive disorder: a comparative study.
    Schrijvers D, Van Den Eede F, Maas Y, Cosyns P, Hulstijn W, Sabbe BG.
    J Affect Disord; 2009 May; 115(1-2):46-53. PubMed ID: 18817977
    [Abstract] [Full Text] [Related]

  • 25. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.
    Maes M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr 29; 35(3):784-94. PubMed ID: 20609377
    [Abstract] [Full Text] [Related]

  • 26. Cognitive deficits in patients with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls.
    Constant EL, Adam S, Gillain B, Lambert M, Masquelier E, Seron X.
    Clin Neurol Neurosurg; 2011 May 29; 113(4):295-302. PubMed ID: 21255911
    [Abstract] [Full Text] [Related]

  • 27. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
    Maes M, Leunis JC, Geffard M, Berk M.
    Neuro Endocrinol Lett; 2014 May 29; 35(6):445-53. PubMed ID: 25433843
    [Abstract] [Full Text] [Related]

  • 28. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.
    Maes M, Galecki P, Chang YS, Berk M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr 29; 35(3):676-92. PubMed ID: 20471444
    [Abstract] [Full Text] [Related]

  • 29. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M, Bosmans E, Kubera M.
    Neuro Endocrinol Lett; 2015 Apr 29; 36(5):439-46. PubMed ID: 26707044
    [Abstract] [Full Text] [Related]

  • 30. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.
    Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
    Neuro Endocrinol Lett; 2009 Apr 29; 30(4):462-9. PubMed ID: 20010493
    [Abstract] [Full Text] [Related]

  • 31. Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome.
    Maes M, Twisk FN, Kubera M, Ringel K, Leunis JC, Geffard M.
    J Affect Disord; 2012 Feb 29; 136(3):909-17. PubMed ID: 21967891
    [Abstract] [Full Text] [Related]

  • 32. Differences in cytokines between non-suicidal patients and suicidal patients in major depression.
    Kim YK, Lee SW, Kim SH, Shim SH, Han SW, Choi SH, Lee BH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):356-61. PubMed ID: 17919797
    [Abstract] [Full Text] [Related]

  • 33. Upregulation of the nitrosylome in bipolar disorder type 1 (BP1) and major depression, but not BP2: Increased IgM antibodies to nitrosylated conjugates are associated with indicants of leaky gut.
    Maes M, Simeonova D, Stoyanov D, Leunis JC.
    Nitric Oxide; 2019 Oct 01; 91():67-76. PubMed ID: 31323278
    [Abstract] [Full Text] [Related]

  • 34. Construction of a nitro-oxidative stress-driven, mechanistic model of mood disorders: A nomothetic network approach.
    Simeonova D, Stoyanov D, Leunis JC, Murdjeva M, Maes M.
    Nitric Oxide; 2021 Jan 01; 106():45-54. PubMed ID: 33186727
    [Abstract] [Full Text] [Related]

  • 35. IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology.
    Maes M, Mihaylova I, Kubera M, Leunis JC, Geffard M.
    J Affect Disord; 2011 Dec 01; 135(1-3):414-8. PubMed ID: 21930301
    [Abstract] [Full Text] [Related]

  • 36. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.
    Maes M.
    Neuro Endocrinol Lett; 2008 Jun 01; 29(3):287-91. PubMed ID: 18580840
    [Abstract] [Full Text] [Related]

  • 37. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.
    Schönfeldt-Lecuona C, Connemann BJ, Wolf RC, Braun M, Freudenmann RW.
    Pharmacopsychiatry; 2006 Jul 01; 39(4):152-4. PubMed ID: 16871471
    [Abstract] [Full Text] [Related]

  • 38. A new case definition of Neuro-Inflammatory and Oxidative Fatigue (NIOF), a neuroprogressive disorder, formerly known as chronic fatigue syndrome or Myalgic Encephalomyelitis: results of multivariate pattern recognition methods and external validation by neuro-immune biomarkers.
    Maes M.
    Neuro Endocrinol Lett; 2015 Jul 01; 36(4):320-9. PubMed ID: 26454487
    [Abstract] [Full Text] [Related]

  • 39. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome.
    Roberts AD, Papadopoulos AS, Wessely S, Chalder T, Cleare AJ.
    J Affect Disord; 2009 May 01; 115(1-2):280-6. PubMed ID: 18937978
    [Abstract] [Full Text] [Related]

  • 40. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
    Papadopoulos A, Ebrecht M, Roberts AD, Poon L, Rohleder N, Cleare AJ.
    J Affect Disord; 2009 Jan 01; 112(1-3):289-94. PubMed ID: 18573538
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.